A型とB型インフルエンザウイルスの重複感染(Influenza A And B Infections)：世界の治験レビュー2014年下半期版...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Influenza A and B Infections 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Influenza A and B Infections to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Influenza A and B Infections to Infectious Disease Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Influenza A and B Infections 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Influenza A and B Infections Therapeutics Clinical Trials 29
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Daiichi Sankyo Company, Limited 32
Clinical Trial Overview of Daiichi Sankyo Company, Limited 32
GlaxoSmithKline plc 33
Clinical Trial Overview of GlaxoSmithKline plc 33
F. Hoffmann-La Roche Ltd. 34
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 34
Microgen Scientific Industrial Company for Immunobiological Medicines 35
Clinical Trial Overview of Microgen Scientific Industrial Company for Immunobiological Medicines 35
Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Co Ltd 36
Clinical Trial Overview of Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Co Ltd 36
Crucell N.V. 37
Clinical Trial Overview of Crucell N.V. 37
Biota Pharmaceuticals, Inc. 38
Clinical Trial Overview of Biota Pharmaceuticals, Inc. 38
Biota Holdings Limited (Inactive) 39
Clinical Trial Overview of Biota Holdings Limited (Inactive) 39
Beech Tree Labs, Inc. 40
Clinical Trial Overview of Beech Tree Labs, Inc. 40
AstraZeneca PLC 41
Clinical Trial Overview of AstraZeneca PLC 41
Clinical Trial Overview of Top Institutes / Government 42
British Columbia Centre for Disease Control 42
Clinical Trial Overview of British Columbia Centre for Disease Control 42
West China Hospital 43
Clinical Trial Overview of West China Hospital 43
Nagasaki Evaluation Organization for Clinical Interventions 44
Clinical Trial Overview of Nagasaki Evaluation Organization for Clinical Interventions 44
TJ-27 Influenza study group 45
Clinical Trial Overview of TJ-27 Influenza study group 45
The National Institute of Allergy and Infectious Diseases 46
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 46
Fukuoka University 47
Clinical Trial Overview of Fukuoka University 47
University of Manitoba 48
Clinical Trial Overview of University of Manitoba 48
University of Surrey 49
Clinical Trial Overview of University of Surrey 49
Five Key Clinical Profiles 50
Appendix 73
Abbreviations 73
Definitions 73
Research Methodology 74
Secondary Research 74
About GlobalData 75
Contact Us 75
Disclaimer 75
Source 75